Vimarsana
Biggest News Aggregation in the World

Peter Berlit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Berlit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Berlit Today - Breaking & Trending Today

Long Covid prevalence vastly overestimated? - Vimarsana News

Long Covid prevalence vastly overestimated?

A group of scientists claim that flawed studies lacking control groups has mislead and increased public anxiety. | Health

Long COVID: prevalence vastly overestimated? – DW – 09/27/2023 - Vimarsana News

Long COVID: prevalence vastly overestimated? – DW – 09/27/2023

A group of scientists claim that the prevalence of long COVID has been vastly overestimated. Flawed studies lacking control groups has mislead and increased public anxiety, they say.

Source: dw.com
Why Long COVID Is Still Such A Mystery To Researchers - Vimarsana News

Why Long COVID Is Still Such A Mystery To Researchers

Both long and post-COVID are still misunderstood by the general public and the scientific community. This can cause even more suffering for those affected, who already fear their symptoms being dismissed as psychosomatic.

Corona: Mehr Guillain-Barré nach Impfung? - Neurologische Reaktion nach Impfung mit Vektor-Vakzinen beobachtet - Vimarsana News

Corona: Mehr Guillain-Barré nach Impfung? - Neurologische Reaktion nach Impfung mit Vektor-Vakzinen beobachtet

Neurologische Reaktion nach Impfung mit Vektor-Vakzinen beobachtet 15. Juli 2021 Es gibt vermehrt Berichte über Fälle des Guillain-Barré-Syndroms nach der Impfung mit Vektor-Vakzinen gegen das Coronavirus – was ist da dran? © wildpixel/ Getty images Neue Nebenwirkung? Erneut gibt es Berichte über eine mögliche Nebenwirkung der Vektor-Impfstoffe gegen das Coronavirus. Demnach sind nach Impfung mit den Vakzinen von AstraZeneca und Johnson & Johnson vermehrt Fälle des Guillain-Barré-Syndroms aufgetreten. Diese neurologische Autoimmunreaktion kann zu Lähmungen führen. Ob allerdings...

Source: scinexx.de
AstraZeneca: What′s the deal with thrombosis? | Science| In-depth reporting on science and technology | DW - Vimarsana News

AstraZeneca: What′s the deal with thrombosis? | Science| In-depth reporting on science and technology | DW

German EU lawmaker Katarina Barley on vaccine dilemmas However, this type of thrombosis is considered rather rare, looking at its incidence: It is estimated that two to five people per 1 million experience CVST over the course of a year. However, recent studies indicate a higher number of people affected. As many as 15.7 cases per million people per year have been reported in an Australian study, says Paul Hunter, professor of medicine at the University of East Anglia. That would mean the current incidence is underestimated by four to eight times, according to Hunter. Does thrombosis always ...

Source: dw.com